feed,title,long_url,short_url
Benzinga,Annexon Shares Gain After Patient Dosing Starts In Mid-Stage Study For Vision Loss Disorder Therapy,https://benzinga.com/general/biotech/21/03/19919702/annexon-shares-gain-after-patient-dosing-starts-in-mid-stage-study-for-vision-loss-disorder-thera,https://j.mp/3q3qLnb
